Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease

por Otten, Antonius T., Bourgonje, Arno R., Horinga, Petra P., van der Meulen, Hedwig H., Festen, Eleonora A. M., van Dullemen, Hendrik M., Weersma, Rinse K., van Leer-Buter, Coretta C., Dijkstra, Gerard, Visschedijk, Marijn C.
Publicado 2022